NCT00004779已完成1 期
Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis
National Center for Research Resources (NCRR)0 个研究点目标入组 12 人开始时间: 1993年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
OBJECTIVES: I. Assess the safety and efficacy of gene transfer into the nasal epithelium using Ad5-CB-CFTR, an E1-deleted adenovirus vector containing the cystic fibrosis transmembrane conductance regulator gene, in patients with cystic fibrosis (CF).
II. Determine whether ion transport abnormalities in CF airway cells can be corrected.
详细描述
PROTOCOL OUTLINE:
Groups of 3 patients receive 1 of 4 doses of Ad5-CB-CFTR, a recombinant E1-deleted adenovirus serotype 5 vector containing the cystic fibrosis transmembrane conductance regulator gene. Ad5-CB-CFTR is administered to 1 nasal cavity and the vehicle alone is administered to the opposite nasal cavity as the control.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics-- Cystic fibrosis No mild genetic mutations, i.e., normal nasal chloride ion permeability At least 2 weeks since decrease in pulmonary function --Prior/Concurrent Therapy-- At least 3 months since systemic cortisone At least 1 month since other therapeutic research study, e.g., DNAse --Patient Characteristics-- Other: Adequate endocrine, liver, kidney, and cardiac function Adenovirus antibody seropositive No pregnant or nursing women Negative pregnancy test required of fertile women Adequate contraception required of fertile patients
排除标准
- 未提供
研究者
相似试验
已完成
1 期
AC6 Gene Transfer for CHFCongestive Heart FailureNCT00787059Hammond, H. Kirk, M.D.56
已完成
1 期
Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic FibrosisCystic FibrosisNCT00004533National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)19
终止
1 期
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseNCT00004386Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
已完成
1 期
A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy AdultsCOVID-19NCT04552366Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China149
尚未招募
2 期
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant MelanomaMalignant MelanomaLiver MetastasesNCT05664139Fujian Cancer Hospital30